HIV 1 Infection: Clinical Trials

1 trial for HIV 1 Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Recruiting 1

Follow HIV 1 Infection: new trials by email Literature Review of HIV 1 Infection trials Research Report on HIV 1 Infection

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE
Bictegravir, emtricitabine, and tenofovir alafenamide - HIV -1 Infection, HIV (Human Immunodeficiency Virus)
Phase 4RecruitingCAN Community Health2002026-06-172026-11-16

Narrower conditions

Acquired Immunodeficiency Syndrome (1)  ·  HIV Infections (1)

Broader conditions

Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  RNA Virus Infections (1)  ·  Retroviridae Infections (1)  ·  Sexually Transmitted Diseases (1)  ·  Sexually Transmitted Diseases, Viral (1)  ·  Slow Virus Diseases (1)  ·  Urogenital Diseases (1)  ·  Virus Diseases (1)

Interventions

bictegravir, emtricitabine, tenofovir alafenamide, drug combination (1)

Sponsors

CAN Community Health (1)

Countries

United States (1)

Top investigators

Hector Bolivar, MD (1)  ·  Jessica Altamirano, MD (1)